Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
Bristol-Myers Squibb
Age
18–79
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subjects in the following groups:
Group A: Healthy Subjects with Normal Renal Function (CLcr \> 80 mL/min) Group B: Diabetic Subjects with Normal Renal Function (CLcr \> 80 mL/min) Group C: Diabetic Subjects with Mild Renal Impairment (CLcr \> 50 - ≤80 mL/min) Group D: Diabetic Subjects with Moderate Renal Impairment (CLcr ≥ 30 - ≤50 mL/min) Group E: Diabetic Subjects with Severe Renal Impairment (CLcr \< 30 mL/min) (and not receiving dialysis)
Men and WOCBP, ages 18 to 79 years old
You may not be if
History of diabetic ketoacidosis
HbA\*1c \> 10%
Serum albumin \< 2.0 gm/dL
Potassium \< 3.0 or \> 6.0 mEq/L
Clareo Health | Renal Impairment in Type 2 Diabetic Subjects
